PPAR gamma and human metabolic disease

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Genetics

Background:

• Peroxisome proliferator-activated receptors (PPARs) were initially identified for their role in response to xenobiotics.
• Human PPAR isotypes (PPARalpha, PPARdelta, PPARgamma) are critical regulators of nutrient sensing and metabolism.
• PPARgamma is primarily involved in lipid assimilation through anabolic pathways.

Purpose of the Study:

• To review the role of PPARgamma in human physiology.
• To examine clinical pharmacological studies involving PPARgamma.
• To analyze PPARG gene variants in relation to metabolic syndrome.

Main Methods:

• Review of clinical pharmacological studies on PPARgamma agonists.
• Analysis of dominant-negative mutations and sequence variants in the PPARG gene.
• Correlation of PPARG variants with abnormal lipid and carbohydrate metabolism.

Main Results:

• Clinical use of PPARgamma agonists has enhanced understanding of its functions.
• Rare dominant-negative PPARG mutations cause partial lipodystrophy and severe insulin resistance.
• Common PPARG sequence variants, though having smaller effects, may significantly impact public health regarding metabolic disease.

Conclusions:

• PPARgamma is a central regulator of human lipid and carbohydrate metabolism.
• Understanding PPARgamma's role and genetic variations is vital for metabolic health.
• Further research into PPARG variants could inform strategies for managing metabolic syndrome.